| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | sugammadex (Bridion®) |
| Formulation | 100 mg/ml solution for injection |
| Reference number | 231 |
| Indication | Reversal of neuromuscular blockade induced by rocuronium or vecuronium. For the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents
|
| Company | Merck Sharp & Dohme Ltd |
| BNF chapter | Anaesthesia |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 07/09/2007 |